Erin DeRuggiero is a healthcare predictive analytics entrepreneur and executive, leading change in healthcare innovation. She is the 2022 recipient of the PM360 Elite Award for Data in addition to being recognized as one of MM+M’s Top 100 Women of Distinction. TI Health was also a nominee for Trailblazer Company of the Year by PM360 Magazine.

As TI Health’s Founder and Chief Executive Officer, Erin brings 25 years of advertising and healthcare experience to the data-driven marketing and analytics company, where she works extensively with leading pharmaceutical manufacturers, medical devices and their respective advertising agencies. Erin guides TI Health to deliver palpable, positive impact for hundreds of therapeutics, devices and brands.

Prior to TI Health, Erin co-founded SRAX, an ad tech startup with a business unit devoted to healthcare marketers, successfully up-listing to NASDAQ two years post launch, a milestone for a female-led startup taking a company public.

Erin served as SRAX’s Chief Innovations Officer until the acquisition and carve out of the healthcare unit she pioneered in August 2018. She was promoted to Chief Executive Officer in January 2021.

Prior to launching SRAX, Erin served as Vice President of Innovation & Digital Strategy for the Lime Ad Network, a subsidiary of Gaiam, Inc, where she oversaw strategic digital partnerships and publisher acquisitions. She also served as the Chief Revenue Officer for JGG Consulting, a successful sales and new business development consultancy she founded, servicing consumer packaged goods and retail brand marketers.